Search

Your search keyword '"Iyer, G."' showing total 862 results

Search Constraints

Start Over You searched for: Author "Iyer, G." Remove constraint Author: "Iyer, G."
862 results on '"Iyer, G."'

Search Results

2. GCAM v5.1: Representing the linkages between energy, water, land, climate, and economic systems

3. Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype

4. Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress)

6. Machine learning for cardiac ultrasound time series data

7. Feasibility of peak temperature targets in light of institutional constraints

8. Comparing net zero pathways across the Atlantic A model inter-comparison exercise between the Energy Modeling Forum 37 and the European Climate and Energy Modeling Forum

9. Three different directions in which the European Union could replace Russian natural gas

11. Competing for attention in social communication markets

12. Comparing transformation pathways across major economies

13. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

15. Plasma Growth and Functionalisation of Carbon Nanotubes and Diamond Nanoflake Spherules

17. Peptide coated quantum dots for biological applications

20. Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 Study of MLN0128 (TAK-228) in Patients with Tumors with TSC1 or TSC2 Mutations: Sub-protocol EAY131-M

21. HER2 as a therapeutic target in bladder cancer

22. 1779TiP Phase II clinical study evaluating the efficacy and safety of disitamab vedotin in patients (pts) with HER2-expressing urothelial carcinoma (RC48G001)

24. 1966MO EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC)

25. A study of 3013 cases of hepatocellular carcinoma: Etiology and therapy before and during the current decade

26. Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized TherapySummary

27. Climate change impacts on the energy system: A model comparison

28. Transparency crucial to Paris climate scenarios—Response

29. Entitäten-unabhängige Sicherheit und Wirksamkeit von Erdafitinib bei Patienten mit fortgeschrittenen soliden Tumoren mit präspezifizierten genomischen FGFR- Aberrationen (RAGNAR Interimanalyse)

30. Successful endovascular management of multiple mycotic aneurysms after liver transplantation – A case report and review of the literature

33. Can updated climate pledges limit warming well below 2 degrees C? Increased ambition and implementation are essential

37. Presence of tumor cells in intra-operative blood salvage autotransfusion samples from hepatocellular carcinoma liver transplantation: analysis using highly sensitive microfluidics technology

38. Identification of a novel inflamed tumor microenvironment signature as a predictive biomarker of bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancer

39. Global roll-out of comprehensive policy measures may aid in bridging emissions gap

40. Can updated climate pledges limit warming well below 2°C?

41. Integrated assessment model diagnostics: key indicators and model evolution

42. Assessing China’s efforts to pursue the 1.5°C warming limit

43. LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

47. Decreasing 30-day Readmissions for Pleural Effusions after Lung Transplant

49. Comparing transformation pathways across major economies

50. Impacts of climate change on energy systems in global and regional scenarios

Catalog

Books, media, physical & digital resources